MedTech Global Insights

The COVID-19 pandemic thrust the In-Vitro Diagnostic (IVD) industry into the global spotlight. This rapid ascent brought unprecedented opportunities but also triggered a wave of intense regulatory scrutiny worldwide. The old ways of bringing a diagnostic test to market are no longer viable in this new, more stringent environment.

This episode of MedTech Global Insights explores the post-pandemic regulatory landscape for IVD manufacturers. We break down the key challenges companies face when seeking international market access, from navigating the EU's rigorous IVDR to managing disparate requirements across dozens of countries. We uncover why a successful domestic launch, even under an Emergency Use Authorization, doesn't guarantee a smooth path to global expansion.

Imagine a fast-growing diagnostics company with a revolutionary testing kit. They are leaders in their home market but find their international expansion plans blocked by a wall of complex, country-specific regulations. Their team is overwhelmed, their launch is delayed, and their competitive advantage is at risk. How can they turn this multi-market challenge into a streamlined, successful global strategy?

Key Takeaways:

- How has the pandemic permanently altered the evidence required for IVD product registration?

- What are the most significant hurdles in transitioning from a US EUA to full approval in the EU under IVDR?

- Why is a 'one-size-fits-all' approach to technical documentation destined for failure in global markets?

- How can AI and data tools accelerate the creation and submission of regulatory dossiers?

- What are the hidden costs of not having local regulatory representation in key international markets?

- Is it possible to use a single, unified process to register a product in over 30 countries simultaneously?

- How do you select the right new markets for your IVD product based on your existing regulatory approvals?

- What post-market surveillance activities are now critical for maintaining compliance globally?

For more information, contact us at [email protected] or visit https://pureglobal.com/.

In this episode of MedTech Global Insights, we explore the explosive trend of wearable medical devices. From smartwatches with ECG features to continuous glucose monitors, the line between consumer tech and regulated medical products is blurring. We break down the critical regulatory pathways these innovative devices must navigate to reach the market.

We cover the essential first step of device classification, dive into the crucial concept of Software as a Medical Device (SaMD), and explain the most common FDA approval route, the 510(k) pathway. Learn how to prepare for global market access, where regulations in Europe, Asia, and the Americas present unique challenges, and discover how a streamlined, strategic approach can pave the way for a successful international launch.

Case Study: A health-tech startup develops a revolutionary algorithm for its smartwatch app that can predict early signs of a stroke. The technology is groundbreaking, but they are stuck. Is the app a low-risk wellness product or a high-risk medical device? Choosing the wrong path could lead to FDA rejection and wasted years of development, while the right strategy could make them the new market leader. This episode tackles the questions they need to answer.

What You'll Learn:

1. When does a simple fitness tracker officially become a regulated medical device?

2. What is Software as a Medical Device (SaMD), and how does it apply to my wearable tech?

3. What are the key components of a successful 510(k) submission to the FDA?

4. How did Continuous Glucose Monitors (CGMs) transition from prescription-only to over-the-counter devices?

5. What are the major regulatory differences between the US FDA and Europe's MDR for wearables?

6. How can you leverage a single technical file to gain access to over 30 countries?

7. What are the most common cybersecurity risks you must address in your FDA submission?

8. Why is local representation in markets like Japan or Brazil critical for regulatory approval?

Contact us at [email protected] or visit https://pureglobal.com/ for more information.